Jeryl Hilleman
Vermögen: 2 Mio $ am 30.06.2026
Vermögen: 2 Mio $ am 30.06.2026
Jeryl Lynn Hilleman is Chairman at Omada Health, Inc. since 2019.
Independent Director at SI-BONE, Inc. since 2019.
Independent Director at NovoCure Ltd. since 2018.
Member of the Henry Crown Fellowship Program since 1999.
Member of the Aspen Global Leadership Network since 1999.
Trustee at GeoHazards International.
Former Independent Director at XenoPort, Inc. from 2005 to 2016.
Director at Talis Biomedical Corp.
from 2021 to 2022.
Director at Cardiva Medical, Inc. Independent Director at Minerva Neurosciences, Inc. from 2018 to 2024.
Independent Director at Cutera, Inc. from 2024 to 2025.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Chief Financial Officer & Vice President-Finance at Geron Corp.
in 1997.
Chief Financial Officer & Executive Vice President at Symyx Technologies, Inc. from 1997 to 2007.
Chief Financial Officer at Amyris, Inc. from 2008 to 2012.
CFO, Secretary, CAO & Head-Investor Relations at OCERA Therapeutics LLC from 2013 to 2014.
Chief Financial Officer & Vice President-Finance at Cytel Corp.
from 1987 to 1999.
Chief Financial Officer at Intersect ENT, Inc. from 2014 to 2019.
Education includes undergraduate degree from Brown University and MBA from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SI-BONE, INC. 0,1 % | 04.06.2026 | 43.772 ( 0,1 % ) | 714 359 $ | 30.06.2026 |
OMADA HEALTH, INC. 0,04 % | 05.07.2026 | 26.655 ( 0,04 % ) | 585 077 $ | 30.06.2026 |
NOVOCURE LTD. 0,02 % | 03.06.2026 | 25.471 ( 0,02 % ) | 385 886 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVOCURE LIMITED | Direktor/Vorstandsmitglied | 25.07.2018 |
| SI-BONE, INC. | Direktor/Vorstandsmitglied | 03.12.2019 |
| OMADA HEALTH, INC. | Vorsitzender | 01.04.2019 |
Aspen Global Leadership Network | Corporate Officer/Principal | 01.01.1999 |
Henry Crown Fellowship Program | Corporate Officer/Principal | 01.01.1999 |
GeoHazards International
GeoHazards International Services to the Health IndustryHealth Services Provides support services for people who are facing problems in natural calamities | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| HILLEVAX, INC. | Direktor/Vorstandsmitglied | 17.09.2025 |
| CUTERA | Direktor/Vorstandsmitglied | 12.02.2025 |
| MINERVA NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.08.2024 |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 20 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Symyx Technologies, Inc.
Symyx Technologies, Inc. Packaged SoftwareTechnology Services Develops research technologies and research software | Technology Services |
Cutera, Inc.
Cutera, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of dermatological problems | Health Technology |
Intersect ENT, Inc.
Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Provides therapy solutions that enable ENT physicians to improve patients | Health Services |
Amyris, Inc.
Amyris, Inc. Chemicals: SpecialtyProcess Industries Operates as a biomanufacturing company that uses renewable biological chemistry | Process Industries |
SI-BONE, Inc.
SI-BONE, Inc. Medical SpecialtiesHealth Technology Operates as a sacroiliac joint medical device company | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
OCERA Therapeutics LLC
OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Cardiva Medical, Inc.
Cardiva Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops vascular closure for patients, hospitals and physicians | Health Technology |
Cytel Corp. | |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Henry Crown Fellowship Program | |
GeoHazards International
GeoHazards International Services to the Health IndustryHealth Services Provides support services for people who are facing problems in natural calamities | Health Services |
Omada Health, Inc.
Omada Health, Inc. Internet Software/ServicesTechnology Services Operates as a virtual care program that pairs with a care team and resources to help your health goals | Technology Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
Aspen Global Leadership Network | |
Talis Biomedical Corp.
Talis Biomedical Corp. Medical SpecialtiesHealth Technology Manufactures testing and diagnostic instruments for infectious diseases | Health Technology |
HilleVax, Inc.
HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen